Adam Palazzo

1PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 18, 2018
The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo.

Adam Palazzo, Sylvia Herter, Laura Grosmaire

Pageof 1

Frequent Collaborators

1 joint publications

Sylvia Herter

1 joint publications

Robert J Oldham

1 joint publications

Anna H Turaj

1 joint publications

Mark S Cragg